A shift from commoditized products liability work—where much of the science is settled, billing rates are often compressed, and settlement values can be fairly predictable—to more high-stakes, bet-the-company-type litigation, has inspired top firms to take on more work in this space.
A shift from commoditized products liability work—where much of the science is settled, billing rates are often compressed, and settlement values can be fairly predictable—to more high-stakes, bet-the-company-type litigation, has inspired top firms to take on more work in this space.
